Intelligo

Private limited company · Tønsberg

NATURE PHARMA NORGE AS

ActiveRetail sale of other food (47.270)

Founded
20 Oct 2020
Chief executive
Dag Tore Skjøthaug
Business address
Bekkeveien 163, 3173 Vear

The life line 2020–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 79.3m.

  1. Managing director took office§ 07
  2. Chair took office§ 07
  3. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

NATURE PHARMA NORGE AS is a private limited company in Tønsberg, founded in 2020, in the industry retail sale of other food. The chief executive is Dag Tore Skjøthaug, and the chair of the board is Terje Andre Skulbru. In 2025 the company had NOK 79.3m in operating revenue and a net profit of NOK 18.6m. The largest owner is XPANDIR SCANDINAVIA AS with 50.0%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 20 Apr 2026

  • Godkjent årsregnskap
  • Endring av forretningsadresse
  • Endring av revisor
  • Varsel om tvangsoppløsning

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

1 point

  • OKEquity ratio 67.1%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 79.3m in 2025

Revenue

NOK 79.3m

+72.8% from 2024

20232025

Operating profit

NOK 23.3m

+190.9% from 2024

20232025

Net profit

NOK 18.6m

+190.4% from 2024

20232025

Equity

NOK 19.0m

+81.9% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Operating costs 71%
  • Left as operating result 29%

Of the net profit for 2025, NOK 8.6m stayed in the company. The rest, NOK 10.0m, is an assumed dividend.

The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts, read 1 Nov 2026

Finances

§ 05 Financial health

Equity ratio 67.1%

RevenueNOK 79.3m Operating margin29.4% Equity ratio67.1% Revenue growth+72.8%
  • NATURE PHARMA NORGE AS, 2025
  • Industry median, assumed: NOK 3.4m · 2.5% · 27.8% · +10.0%

Equity NOK 19.0m67% of the assets (NOK 28.4m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 462 companies in 47.270 Retail sale of other food, not stated by the source.

Finances

§ 06 Accounts

6 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue79,26145,88228,067
Operating profit23,3338,0214,508
Profit before tax23,8158,2064,383
Net profit18,5716,3943,500
Total assets28,37716,6597,254
Equity19,03010,4594,065
Liabilities9,3476,2003,189

Source: the Register of Company Accounts, read 15 Nov 2026 · All 6 years →

Management and ownership

§ 07 Officers

5 officers now

The board: 2 members

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 5 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Styrets medlemmer hver for seg.

May sign for the company:

Styrets medlemmer hver for seg.

Procuration: none registered.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 4 Oct 2026

Management and ownership

§ 09 Owners

2 shareholders · largest 50.0%

OwnerShare
XPANDIR SCANDINAVIA AS
50.0%
YOU LEARN AS
24.5%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 2 owners →

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

14 connections

  • Person
  • Company

3 people link NATURE PHARMA NORGE AS to 10 other companies: Terje Andre Skulbru 6, Daniel Helmut Podpeskar-Johansen 5 and Dag Tore Skjøthaug 2.

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →

Events and registers

§ 13 Events

13 since 2020

Events per year

20202026

  • Notices12
  • Owners in and out1

Since 2020: 12 announcements and 1 new and 0 former owners. Most happened in 2021 and 2023.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 1 Nov 2026. Register changes are Intelligo's own observations. · All 13 events →

Events and registers

§ 14 Notices

12, latest 20 Apr 2026

  • Godkjente årsregnskap
  • Godkjente årsregnskap
  • Godkjente årsregnskap

Source: The Brønnøysund Register Centre's announcements ↗, read 1 Nov 2026 · All 12 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 6 Nov 2020
  • VATRegistered
  • The Register of Business EnterprisesRegistered 6 Nov 2020
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Handel innenfor helsekost- og naturprodukter, samt andre produkter/tjenester som står i naturlig forbindelse med dette, herunder deltakelse i andre selskaper.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 47.270

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

7 questions

  • Who is the chief executive of NATURE PHARMA NORGE AS?
    Dag Tore Skjøthaug, since 2022. § 07
  • Who owns NATURE PHARMA NORGE AS?
    2 shareholders. The largest is XPANDIR SCANDINAVIA AS with 50.0% and YOU LEARN AS with 24.5%. § 09
  • What was the revenue in 2025?
    NOK 79.3m in the company. § 06
  • Who can sign for NATURE PHARMA NORGE AS?
    Styrets medlemmer hver for seg. § 08
  • Who is the auditor?
    REVICOM AS, from 29 Aug 2023. § 07
  • Where is NATURE PHARMA NORGE AS based?
    Bekkeveien 163, 3173 Vear.
  • When was NATURE PHARMA NORGE AS founded?
    20 Oct 2020, registered in the Register of Business Enterprises 6 Nov 2020. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose